Evaluation of the effect of probiotics in resistant pediatric epilepsy

Phase 2

Recruiting

• Conditions: Resistant epilepsy.; Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus; G40.1

• Registration Number: IRCT20200519047517N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age 1 year to 15 years
Having at least one seizure a month despite using anticonvulsants for the past three months
Taking at least 3 anticonvulsant drugs as a single drug with appropriate amount and duration (at least 2 months) and lack of seizure control
No history of hypertension
Absence of active infection
No history of gastrointestinal ulcers

Exclusion Criteria

Infants with infantile spasm
Recent history of pseudo-seizures
Active infection
History of hypertension
History of gastrointestinal ulcers in patients
Patients who terminated the treatment plan earlier than scheduled due to personal reasons, lack of necessary cooperation and communication.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of epileptic seizures per month. Timepoint: One Month. Method of measurement: The ZARIT burden questionnaire.